Guardion Health Sciences, Inc.
Guardion Health Sciences, Inc. (GHSI) Revenue
Annual & quarterly revenue history · segment & region breakdown
GHSI · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsGuardion Health Sciences, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare GHSI revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Guardion Health Sciences, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Guardion Health Sciences, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Guardion Health Sciences, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GHSI revenue · 4 questionsGHSI's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Guardion Health Sciences, Inc. SEC filings · GAAP · Guardion Health Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026